Acetylcholinesterase inhibitors are used for the symptomatic management of several neurological diseases, senile dementia, ataxia, Myasthenia Gravis, Parkinson’s disease, and Alzheimer’s disease [68]. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.